FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1235.342.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.342/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342
Version20230808
Statusactive
Date2023-08-08T01:00:54-04:00
NameAFibAtrialFibrillation_RxNORM
TitleAFib (Atrial Fibrillation)_RxNORM
Realmus
Authorityhl7
Descriptionb.well created value set by Sr. Clinical Business Analyst for A-Fib Condition.
Purpose(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute A-Fib Condition for inclusion and utilization in patients/users connected heath.),(Data Element Scope: A-Fib Condition for b.well.),(Inclusion Criteria: A-Fib RxNORM Codes that constitute the Primary A-Fib Condition for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1235.344AFib (Atrial Fibrillation)_Clinical Condition Grouping

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.342",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-09-24"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-08-08"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.342"
    }
  ],
  "version": "20230808",
  "name": "AFibAtrialFibrillation_RxNORM",
  "title": "AFib (Atrial Fibrillation)_RxNORM",
  "status": "active",
  "date": "2023-08-08T01:00:54-04:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for A-Fib Condition.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute A-Fib Condition for inclusion and utilization in patients/users connected heath.),(Data Element Scope: A-Fib Condition for b.well.),(Inclusion Criteria: A-Fib RxNORM Codes that constitute the Primary A-Fib Condition for b.well.),(Exclusion Criteria: N/A)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1922720",
            "display": "Atrial Fibrillation sotalol hydrochloride 120 MG Oral Tablet"
          },
          {
            "code": "1922721",
            "display": "Atrial Fibrillation sotalol hydrochloride 120 MG Oral Tablet [Betapace]"
          },
          {
            "code": "1922763",
            "display": "Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet"
          },
          {
            "code": "1922764",
            "display": "Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet [Betapace]"
          },
          {
            "code": "1922765",
            "display": "Atrial Fibrillation sotalol hydrochloride 80 MG Oral Tablet"
          },
          {
            "code": "1922766",
            "display": "Atrial Fibrillation sotalol hydrochloride 80 MG Oral Tablet [Betapace]"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:dfa51839-ba67-4ca7-a636-c444d7699758",
    "timestamp": "2025-05-23T20:23:34-04:00",
    "total": 6,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922720",
        "display": "Atrial Fibrillation sotalol hydrochloride 120 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922721",
        "display": "Atrial Fibrillation sotalol hydrochloride 120 MG Oral Tablet [Betapace]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922763",
        "display": "Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922764",
        "display": "Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet [Betapace]"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922765",
        "display": "Atrial Fibrillation sotalol hydrochloride 80 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922766",
        "display": "Atrial Fibrillation sotalol hydrochloride 80 MG Oral Tablet [Betapace]"
      }
    ]
  }
}